SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Lin Yi) "

Sökning: WFRF:(Lin Yi)

  • Resultat 31-40 av 393
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
31.
  • Wang, Fei, et al. (författare)
  • Endothelial cell heterogeneity and microglia regulons revealed by a pig cell landscape at single-cell level
  • 2022
  • Ingår i: Nature Communications. - : Springer Nature. - 2041-1723. ; 13:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Pigs are valuable large animal models for biomedical and genetic research, but insights into the tissue- and cell-type-specific transcriptome and heterogeneity remain limited. By leveraging single-cell RNA sequencing, we generate a multiple-organ single-cell transcriptomic map containing over 200,000 pig cells from 20 tissues/organs. We comprehensively characterize the heterogeneity of cells in tissues and identify 234 cell clusters, representing 58 major cell types. In-depth integrative analysis of endothelial cells reveals a high degree of heterogeneity. We identify several functionally distinct endothelial cell phenotypes, including an endothelial to mesenchymal transition subtype in adipose tissues. Intercellular communication analysis predicts tissue- and cell type-specific crosstalk between endothelial cells and other cell types through the VEGF, PDGF, TGF-beta, and BMP pathways. Regulon analysis of single-cell transcriptome of microglia in pig and 12 other species further identifies MEF2C as an evolutionally conserved regulon in the microglia. Our work describes the landscape of single-cell transcriptomes within diverse pig organs and identifies the heterogeneity of endothelial cells and evolutionally conserved regulon in microglia.
  •  
32.
  • Weinstein, John N., et al. (författare)
  • The cancer genome atlas pan-cancer analysis project
  • 2013
  • Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 45:10, s. 1113-1120
  • Forskningsöversikt (refereegranskat)abstract
    • The Cancer Genome Atlas (TCGA) Research Network has profiled and analyzed large numbers of human tumors to discover molecular aberrations at the DNA, RNA, protein and epigenetic levels. The resulting rich data provide a major opportunity to develop an integrated picture of commonalities, differences and emergent themes across tumor lineages. The Pan-Cancer initiative compares the first 12 tumor types profiled by TCGA. Analysis of the molecular aberrations and their functional roles across tumor types will teach us how to extend therapies effective in one cancer type to others with a similar genomic profile. © 2013 Nature America, Inc. All rights reserved.
  •  
33.
  • Willer, Cristen J., et al. (författare)
  • Discovery and refinement of loci associated with lipid levels
  • 2013
  • Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 45:11, s. 1274-1283
  • Tidskriftsartikel (refereegranskat)abstract
    • Levels of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides and total cholesterol are heritable, modifiable risk factors for coronary artery disease. To identify new loci and refine known loci influencing these lipids, we examined 188,577 individuals using genome-wide and custom genotyping arrays. We identify and annotate 157 loci associated with lipid levels at P < 5 x 10(-8), including 62 loci not previously associated with lipid levels in humans. Using dense genotyping in individuals of European, East Asian, South Asian and African ancestry, we narrow association signals in 12 loci. We find that loci associated with blood lipid levels are often associated with cardiovascular and metabolic traits, including coronary artery disease, type 2 diabetes, blood pressure, waist-hip ratio and body mass index. Our results demonstrate the value of using genetic data from individuals of diverse ancestry and provide insights into the biological mechanisms regulating blood lipids to guide future genetic, biological and therapeutic research.
  •  
34.
  • Wu, Ping-Hsun, et al. (författare)
  • Associations of Bone Turnover Markers with Cognitive Function in Patients Undergoing Hemodialysis
  • 2020
  • Ingår i: Disease Markers. - : HINDAWI LTD. - 0278-0240 .- 1875-8630. ; 2020
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Patients undergoing hemodialysis experience a greater risk of cognitive impairment than the general population, but limited data elucidates the biomarkers on this. We evaluated the association of bone turnover markers on cognitive function among 251 prevalent hemodialysis enrollees in a cross-sectional study.Methods: 251 hemodialysis patients (median age=57.8, 55% men) and 37 control subjects (mean age=61.2, 56% men) without a prior stroke or dementia diagnosis were enrolled. Serum concentrations of 8 bone markers were analyzed as the association of cognitive function (Montreal Cognitive Assessment (MoCA) and Cognitive Abilities Screening Instrument (CASI)) using linear regression analysis.Results: A lower cognitive function was noted in hemodialysis patients compared to control subjects. The receptor activator of nuclear factor kappa-B ligand (RANKL) was the only bone marker found to be associated with cognitive function (MoCA and CASI tests) in hemodialysis patients without a prior stroke or dementia diagnosis. In stepwise multiple linear regression analysis, the association remained significant in MoCA (beta=1.14, 95% CI 0.17 to 2.11) and CASI (beta=3.06, 95% CI 0.24 to 5.88). Short-term memory (beta=0.52, 95% CI 0.01 to 1.02), mental manipulation (beta=0.51, 95% CI 0.05 to 0.96), and abstract thinking (beta=0.57, 95% CI 0.06 to 1.09) were the significant subdomains in the CASI score related to RANKL.Conclusions: Serum RANKL levels were potentially associated with better cognitive function in hemodialysis patients. Further large-scale and prospective studies are needed to confirm our findings.
  •  
35.
  • Wu, Ping-Hsun, et al. (författare)
  • Comparative Gut Microbiome Differences between Ferric Citrate and Calcium Carbonate Phosphate Binders in Patients with End-Stage Kidney Disease
  • 2020
  • Ingår i: Microorganisms. - : MDPI. - 2076-2607. ; 8:12
  • Tidskriftsartikel (refereegranskat)abstract
    • Gut dysbiosis in patients with chronic kidney disease (CKD) may induce chronic inflammation and increase morbidity. Phosphate-binding agents, generally used in patients with CKD, may potentially change the composition of the gut microbiota. This study aimed to compare the microbiota composition in hemodialysis patients treated with ferric citrate or calcium carbonate. The stool microbiota was investigated in hemodialysis patients treated with ferric citrate (n = 8) and calcium carbonate (n = 46) using 16S rRNA gene amplicon sequencing profiling using linear discriminant analysis of effect size. Further predictive functional profiling of microbial communities was obtained with Tax4Fun in R. Hemodialysis patients treated with calcium carbonate had a significantly reduced microbial species diversity (Shannon index and Simpson index) and an increased microbial alteration ratio compared with patients treated with ferric citrate. A distinct microbial community structure was found in patients treated with ferric citrate, with an increased abundance of the Bacteroidetes phylum and a decreased abundance of the phylum Firmicutes. Members of the order Lactobacillales were enriched in patients treated with calcium carbonate, whereas taxa of the genera Ruminococcaceae UCG-004, Flavonifractor, and Cronobacter were enriched in patients treated with ferric citrate phosphate binder. In conclusion, Ferric citrate therapy results in a more diverse microbiome community compared to calcium carbonate therapy in hemodialysis patients with phosphate binder treatment. The gut microbiome reflects the phosphate binder choice in hemodialysis patients, further affecting the physiological environment in the gastrointestinal tract.
  •  
36.
  • Wu, Ping-Hsun, et al. (författare)
  • Exploring the Benefit of 2-Methylbutyric Acid in Patients Undergoing Hemodialysis Using a Cardiovascular Proteomics Approach
  • 2019
  • Ingår i: Nutrients. - : MDPI. - 2072-6643. ; 11:12
  • Tidskriftsartikel (refereegranskat)abstract
    • Short-chain fatty acids (SCFAs) can reduce pro-inflammatory parameters and oxidative stress, providing potential cardiovascular (CV) benefits. Although some evidence links SCFAs with host metabolic health via several biological mechanisms, the role of SCFA on CV disease in patients with kidney disease remains unclear. Herein, we investigate the association between a SCFA, 2-methylbutyric acid, and target CV proteomics to explore the potential pathophysiology of SCFA-related CV benefit in patients with kidney disease. Circulating 2-methylbutyric acid was quantified by high-performance liquid chromatography and 181 CV proteins by a proximity extension assay in 163 patients undergoing hemodialysis (HD). The associations between 2-methylbutyric acid and CV proteins were evaluated using linear regression analysis with age and gender, and multiple testing adjustment. The selected CV protein in the discovery phase was further confirmed in multivariable-adjusted models and evaluated by continuous scale association. The mean value of circulating 2-methylbutyric acid was 0.22 +/- 0.02 mu m which was negatively associated with bone morphogenetic protein 6 (BMP-6) according to the false discovery rate (FDR) multiple testing adjustment method. The 2-methylbutyric acid level remained negatively associated with BMP-6 (beta coefficient -1.00, 95% confidence interval -1.45 to -0.55, p < 0.001) after controlling for other CV risk factors in multivariable models. The cubic spline curve demonstrated a linear relationship. In conclusion, circulating 2-methylbutyric acid level was negatively associated with BMP-6, suggesting that this pathway maybe involved in vascular health in patients undergoing HD. However, further in vitro work is still needed to validate the translation of the mechanistic pathways.
  •  
37.
  • Wu, Ping-Hsun, et al. (författare)
  • β-blocker dialyzability and the risk of mortality and cardiovascular events in patients undergoing hemodialysis
  • 2020
  • Ingår i: Nephrology, Dialysis and Transplantation. - : Oxford University Press (OUP). - 0931-0509 .- 1460-2385. ; 35:11, s. 1959-1965
  • Tidskriftsartikel (refereegranskat)abstract
    • Backgroundβ-blocker (BB) dialyzability has been proposed to limit their efficacy among hemodialysis (HD) patients. We attempted to confirm this hypothesis by comparing health outcomes associated with the initiation of dialyzable or nondialyzable BBs in a nationwide cohort of HD patients.MethodsWe created a prospective cohort study of 15 699 HD patients who initiated dialyzable BBs (atenolol, acebutolol, metoprolol and bisoprolol) and 20 904 hemodialysis patients who initiated nondialyzable BBs (betaxolol, carvedilol and propranolol) between 2004 and 2011 in Taiwan healthcare. We compared the risk of all-cause mortality and major adverse cardiovascular events (MACEs, a composite of the acute coronary syndrome, ischemic stroke and heart failure) between users of dialyzable versus nondialyzable BBs during a 2-year follow-up.ResultsNew users of dialyzable BBs were younger, more often men, with diabetes mellitus, hypertension and hyperlipidemia compared with users of nondialyzable BBs. Compared with nondialyzable BBs, initiation of dialyzable BBs was associated with lower all-cause mortality {hazard ratio [HR] 0.82 [95% confidence interval (CI) 0.75–0.88]} and lower risk of MACEs [HR 0.89 (95% CI 0.84–0.93)]. Results were confirmed in subgroup analyses, censoring at BB discontinuation or switch, after 1:1 propensity score matching, reclassifying bisoprolol or excluding bisoprolol/carvedilol users.ConclusionsThis study does not offer support for the hypothesis that the dialyzability of BBs reduces their efficacy in HD patients.
  •  
38.
  • Xu, Hai-Sen, et al. (författare)
  • Single crystal of a one-dimensional metallo-covalent organic framework
  • 2020
  • Ingår i: Nature Communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 11:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Although polymers have been studied for well over a century, there are few examples of covalently linked polymer crystals synthesised directly from solution. One-dimensional (1D) covalent polymers that are packed into a framework structure can be viewed as a 1D covalent organic framework (COF), but making a single crystal of this has been elusive. Herein, by combining labile metal coordination and dynamic covalent chemistry, we discover a strategy to synthesise single-crystal metallo-COFs under solvothermal conditions. The single-crystal structure is rigorously solved using single-crystal electron diffraction technique. The non-centrosymmetric metallo-COF allows second harmonic generation. Due to the presence of syntactic pendant amine groups along the polymer chains, the metallopolymer crystal can be further cross-linked into a crystalline woven network. Although polymers have been studied for well over a century, there are few examples of covalently linked polymer crystals synthesized directly from solution. Here, the authors demonstrate a strategy to synthesize single crystalline 1D metallo-covalent organic frameworks by combining dynamic covalent chemistry and metal-ligand coordination.
  •  
39.
  • Yi-Ting, Lin, et al. (författare)
  • Indole-3 acetic acid increased risk of impaired cognitive function in patients receiving hemodialysis
  • 2019
  • Ingår i: Neurotoxicology. - : Elsevier BV. - 0161-813X .- 1872-9711. ; 73, s. 85-91
  • Tidskriftsartikel (refereegranskat)abstract
    • Patients receiving hemodialysis (HD) have a higher risk of cognitive impairment and dementia than the general population. The accumulation of uremic toxins in the brain causes uremic encephalopathy, however, limited data exists to elucidate the effect of protein-bound uremic toxins on cognitive function. Here we investigate the effect of indole-3 acetic acid (IAA) and hippuric acid (HA), two different protein-bound uremic toxins from amino acid derivatives, on cognitive function by Silico and in a clinical study. Prevalent HD patients were enrolled in two independent hospitals. Serum IAA and HA were measured using mass spectrometry. Cognitive performance was measured using Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Cognitive Abilities Screening Instrument (CASI) by trained psychologists. Using silico data to predict the effect of blood-brain barrier penetration was performed. The silico data demonstrated that IAA and HA had positive blood-brain barrier penetration ability. Amongst the 230 HD patients, serum IAA was associated with poor MMSE score (beta = -0.90, 95% CI -1.61 to -0.19) and poor CASI score (beta = -3.29, 95% CI -5.69 to -0.88) in stepwise multiple linear regression analysis. In logistic regression model, Serum IAA was also associated with cognitive impairment based on MMSE definition (OR, 1.96, 95% CI 1.10, 3.5) and CASI definition (OR, 2.09, 95% CI 1.21, 3.61). There was no correlation between Serum HA levels and cognitive function status. In conclusion, IAA, not HA, was associated with cognitive impairment in HD patients. Further large scale and prospective studies are needed to confirm our findings.
  •  
40.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 31-40 av 393
Typ av publikation
tidskriftsartikel (348)
forskningsöversikt (19)
konferensbidrag (13)
annan publikation (4)
rapport (3)
doktorsavhandling (3)
visa fler...
visa färre...
Typ av innehåll
refereegranskat (375)
övrigt vetenskapligt/konstnärligt (15)
Författare/redaktör
Luo, Yi (36)
Brenner, Hermann (34)
Lin, Yi (33)
Peters, Ulrike (32)
Berndt, Sonja I (29)
Giles, Graham G (29)
visa fler...
Campbell, Peter T. (26)
Chang-Claude, Jenny (25)
Newcomb, Polly A. (25)
Gunter, Marc J. (24)
Hoffmeister, Michael (24)
van Guelpen, Bethany (24)
Hsu, Li (24)
Harrison, Tabitha A. (23)
Moreno, Victor (23)
Qiu, Chengxuan (23)
Wang, Yongxiang (23)
Du, Yifeng (23)
Dong, Yi (23)
Buchanan, Daniel D. (22)
Cong, Lin (22)
Lind, Lars (21)
Wolk, Alicja (21)
Chan, Andrew T. (21)
Murphy, Neil (21)
Hou, Tingting (21)
Jenkins, Mark A. (20)
Figueiredo, Jane C. (19)
Ogino, Shuji (19)
Slattery, Martha L. (19)
White, Emily (19)
Pakpour, Amir H. (18)
Casey, Graham (18)
Sakoda, Lori C. (18)
Woods, Michael O. (18)
Albanes, Demetrius (17)
Thibodeau, Stephen N (17)
Gallinger, Steven (17)
Schoen, Robert E. (17)
Zheng, Wei (17)
Le Marchand, Loïc (17)
Lin, Chung-Ying (17)
Qu, Conghui (16)
Gruber, Stephen B. (16)
Li, Li (16)
Yang, Yi (16)
Chanock, Stephen J (15)
Sundström, Johan, Pr ... (15)
Potter, John D. (15)
Rennert, Gad (15)
visa färre...
Lärosäte
Uppsala universitet (116)
Karolinska Institutet (88)
Lunds universitet (71)
Umeå universitet (60)
Kungliga Tekniska Högskolan (59)
Stockholms universitet (54)
visa fler...
Göteborgs universitet (31)
Chalmers tekniska högskola (26)
Jönköping University (20)
Linköpings universitet (19)
Högskolan Dalarna (10)
Luleå tekniska universitet (7)
Sveriges Lantbruksuniversitet (7)
Högskolan i Skövde (5)
Örebro universitet (4)
Naturhistoriska riksmuseet (4)
Mälardalens universitet (3)
RISE (3)
Högskolan Kristianstad (2)
Linnéuniversitetet (2)
Karlstads universitet (2)
Högskolan i Halmstad (1)
Malmö universitet (1)
Södertörns högskola (1)
visa färre...
Språk
Engelska (390)
Odefinierat språk (3)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (190)
Naturvetenskap (148)
Teknik (37)
Samhällsvetenskap (15)
Lantbruksvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy